These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23239123)

  • 1. Empirically driven definitions of "good," "moderate," and "poor" levels of functioning in the treatment of schizophrenia.
    Ascher-Svanum H; Novick D; Haro JM; Aguado J; Cui Z
    Qual Life Res; 2013 Oct; 22(8):2085-94. PubMed ID: 23239123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia.
    Witte MM; Case MG; Schuh KJ; Ascher-Svanum H
    Curr Med Res Opin; 2012 Mar; 28(3):315-23. PubMed ID: 22236137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
    Tollefson GD; Andersen SW
    J Clin Psychiatry; 1999; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cluster-analytical approach toward real-world outcome in outpatients with stable schizophrenia.
    Rocca P; Montemagni C; Mingrone C; Crivelli B; Sigaudo M; Bogetto F
    Eur Psychiatry; 2016 Feb; 32():48-54. PubMed ID: 26803615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abbreviated quality of life scales for schizophrenia: comparison and utility of two brief community functioning measures.
    Fervaha G; Foussias G; Siddiqui I; Agid O; Remington G
    Schizophr Res; 2014 Apr; 154(1-3):89-92. PubMed ID: 24630140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia.
    Perlick DA; Rosenheck RA; Kaczynski R; Bingham S; Collins J
    Schizophr Res; 2008 Feb; 99(1-3):192-9. PubMed ID: 17851042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function.
    Kleinman L; Lieberman J; Dube S; Mohs R; Zhao Y; Kinon B; Carpenter W; Harvey PD; Green MF; Keefe RS; Frank L; Bowman L; Revicki DA
    Schizophr Res; 2009 Feb; 107(2-3):275-85. PubMed ID: 19013769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in stable schizophrenia: the relative contributions of disorganization and cognitive dysfunction.
    Sigaudo M; Crivelli B; Castagna F; Giugiario M; Mingrone C; Montemagni C; Rocca G; Rocca P
    Schizophr Res; 2014 Mar; 153(1-3):196-203. PubMed ID: 24485197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone.
    Phillips GA; Van Brunt DL; Roychowdhury SM; Xu W; Naber D
    J Clin Psychiatry; 2006 Sep; 67(9):1397-403. PubMed ID: 17017826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes.
    Dunayevich E; Sethuraman G; Enerson M; Taylor CC; Lin D
    Schizophr Res; 2006 Sep; 86(1-3):300-8. PubMed ID: 16860974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study.
    Cuyún Carter GB; Milton DR; Ascher-Svanum H; Faries DE
    BMC Psychiatry; 2011 Aug; 11():143. PubMed ID: 21871092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy.
    Lipkovich IA; Deberdt W; Csernansky JG; Sabbe B; Keefe RS; Kollack-Walker S
    BMC Psychiatry; 2009 Jul; 9():44. PubMed ID: 19602273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of an abbreviated quality of life scale for schizophrenia.
    Fervaha G; Remington G
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1072-7. PubMed ID: 23235268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning.
    Kinon BJ; Noordsy DL; Liu-Seifert H; Gulliver AH; Ascher-Svanum H; Kollack-Walker S
    J Clin Psychopharmacol; 2006 Oct; 26(5):453-61. PubMed ID: 16974184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study.
    San L; Ciudad A; Alvarez E; Bobes J; Gilaberte I
    Eur Psychiatry; 2007 Nov; 22(8):490-8. PubMed ID: 17904337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.
    Wehmeier PM; Kluge M; Schacht A; Helsberg K; Schreiber W; Schimmelmann BG; Lambert M
    J Psychiatr Res; 2008 Jul; 42(8):676-83. PubMed ID: 17720192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: relationship to functioning and Quality of Life.
    Kasckow J; Montross L; Golshan S; Mohamed S; Patterson T; Sollanzano E; Zisook S
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1223-8. PubMed ID: 17506025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.